These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 25941348
1. Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies. Alnima T, Goedhart EJ, Seelen R, van der Grinten CP, de Leeuw PW, Kroon AA. Hypertension; 2015 Jun; 65(6):1217-22. PubMed ID: 25941348 [Abstract] [Full Text] [Related]
2. Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension. Alnima T, Scheffers I, De Leeuw PW, Winkens B, Jongen-Vancraybex H, Tordoir JH, Schmidli J, Mohaupt MG, Allemann Y, Kroon AA. J Hypertens; 2012 Aug; 30(8):1665-70. PubMed ID: 22728906 [Abstract] [Full Text] [Related]
6. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. Illig KA, Levy M, Sanchez L, Trachiotis GD, Shanley C, Irwin E, Pertile T, Kieval R, Cody R. J Vasc Surg; 2006 Dec; 44(6):1213-1218. PubMed ID: 17145423 [Abstract] [Full Text] [Related]
7. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD. J Am Soc Hypertens; 2012 Dec; 6(2):152-8. PubMed ID: 22341199 [Abstract] [Full Text] [Related]
10. Efficacy of Electrical Baroreflex Activation Is Independent of Peripheral Chemoreceptor Modulation. Heusser K, Thöne A, Lipp A, Menne J, Beige J, Reuter H, Hoffmann F, Halbach M, Eckert S, Wallbach M, Koziolek M, Haarmann H, Joyner MJ, Paton JFR, Diedrich A, Haller H, Jordan J, Tank J. Hypertension; 2020 Jan; 75(1):257-264. PubMed ID: 31786986 [Abstract] [Full Text] [Related]
13. Rheos: an implantable carotid sinus stimulation device for the nonpharmacologic treatment of resistant hypertension. Ng MM, Sica DA, Frishman WH. Cardiol Rev; 2011 Jan; 19(2):52-7. PubMed ID: 21285662 [Abstract] [Full Text] [Related]
14. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, Cates AW, Lovett EG, Haller H. J Am Soc Hypertens; 2012 Jan; 6(4):270-6. PubMed ID: 22694986 [Abstract] [Full Text] [Related]